Here are the key details to know:
1. Through completion of the merger, Envision is a wholly-owned subsidiary of KKR.
2. Envision stockholders will receive $46 per share as a result of the merger.
3. The $9.9 billion acquisition was announced in June.
4. Following the acquisition, Envision (AmSurg) will have about 300 ASCs in its porfolio.
More articles on transactions and valuation:
KKR will have about 300 ASCs in its portfolio after Envision acquisition
Surgery Partners renews M&A push with plans to raise $115M — 7 insights
3 experts share their thoughts on surgery center M&A
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
